medigraphic.com

2012, Number 2

<< Back Next >>

Rev Med MD 2012; 3.4 (2)

Prevalence of premature babies at visual risk and type 1 retinopathy of prematurity in the Civil Hospital of Guadalajara

Zepeda-Romero LC, Aguirre-Jáuregui Ó, Angulo-Castellanos E, Gómez-Ruiz LM, Meza-Anguiano A, Quezada-Chalita A, Gutiérrez-Padilla JA

Language: Spanish
References: 16
Page: 63-67
PDF size: 2519.92 Kb.


ABSTRACT

Introduction: The retinopathy of prematurity (ROP) is the main cause of child blindness in Latin America. In Mexico there are few epidemiologic data, however, it has been reported a prevalence of ROP type 1 from 6.1% to 15% on premature newborns. In Guadalajara, it is the cause of 35% of the admittances to schools for the blind.
Material and methods: Longitudinal prospective study, in which are reported 6 years of experience of the ROP detection and treatment program by the Organismo Publico Descentralizado (O.P.D.) Civil Hospital of Guadalajara.
Results: During the period of 2004-2010 were found 12.3% premature births, and from this number 21.1% were admitted to the protocol of ROP detection and treatment. From which, 15% were diagnosed with type 1 ROP and intervened with laser, achieving an anatomic success of 92% of the cases. These results are compared with other Mexican reports and the causes of current epidemics discussed.
Conclusion: The premature patient in their first weeks of life is the individual with the most risk of irreversible blindness. Every premature patient at risk must have access to the timely detection of ROP.


REFERENCES

  1. Gilbert C. Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev. 2008 Feb;84(2):77-82.

  2. Zepeda-Romero LC, Barrera-de-Leon JC, Camacho-Choza C, Gonzalez Bernal C, Camarena-Garcia E, Diaz-Alatorre C, Gutierrez- Padilla JA, Gilbert C. Retinopathy of prematurity as a major cause of severe visual impairment and blindness in children in schools for the blind in Guadalajara city, Mexico. Br J Ophthalmol. 2011 ;95:1502-5

  3. Gilbert CE, Foster A. Childhood blindness in the context of VISION 2020-the right to sight. Bull WHO 2001b;79:227-32.

  4. Zepeda-Romero LC, Gutiérrez-Padilla JA, De la Fuente-Torres MA, Angulo-Castellanos E, Ramos- Padilla E, Quinn GE. Detection and treatment for retinopathy of prematurity in Mexico: need for effective programs. J AAPOS. 2008;12(3):225-226.

  5. Good WV, Hardy RJ, Dobson V, Palmer EA, Phelps DL, Quintos M, et al; Early Treatment for Retinopathy of Prematurity Cooperative Group. The incidence and course of retinopathy of prematurity: findings from the early treatment for retinopathy of prematurity study. Pediatrics. 2005 Jul;116(1):15-23.

  6. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005 Jul;123(7):991-9.

  7. Gilbert C, Fielder F, Gordillo L, Quinn G, Semiglia R, Visintin P, Zin A; for the International NO-ROP Group. Characteristics of babies with severe retinopathy of prematurity in countries with low, moderate and high levels of development; implications for screening programs. Pediatrics 2005; 115:e518-e525.

  8. Orozco-Gómez LP, Ruiz-Morfín I, Lámbarry- Arroyo A, Morales-Cruz MV. Prevalence of premature retinopathy. 12-year detection in hospital "20 de Noviembre“. Cir Cir. 2006;74(1):3-9.

  9. Lavalle-Villalobos A, Flores-Nava G, Solares-Pineda M, Pérez-Bernabé M, de la Fuente-Torres MA. Factores de riesgo asociados a retinopatía del prematuro. Rev Mex Ped 2005;(5): 221-225.

  10. Ramírez-Ortíz MA, Villa-Guillén M, Villanueva- García D, Murguía-de-Sierra T, Saucedo-Castillo A, Etulain-González A. Criterios de tamizaje en el examen ocular de prematuros mexicanos con riesgo de desarrollo de ceguera irreversible por retinopatía de la prematurez. Bol Med Hosp Infant Mex 2008;65(3):179-185.

  11. Flores-Santos R, Hernández-Cabrera MA, Hernández-Herrera RJ, Sepúlveda-Cañamar F. Screening for retinopathy of prematurity: results of a 7-year study of underweight newborns. Arch Med Res. 2007;38(4):440-3.

  12. Sánchez-Buenfil E, Zapata-Ceballos G, Escamilla- Sosa M. Retinopatía en el prematuro menor a 1500 g expuesto a concentraciones altas de oxígeno suplementario. Incidencia en Yucatán. Rev Mex Oftal 2008;82(6) 381-384.

  13. Vazquez-Lara Yolanda, Bravo-Ortiz Juan C, Hernandez-Galvan C. Factores asociados con un mayor riesgo de retinopatía del prematuro en recién nacidos prematuros atendidos en un hospital de tercer nivel. Bol. Hosp. Infant Mex 2012:69(4)277- 282

  14. Instituto Nacional de Estadística Geografía e Informática. Anuario de estadísticas por Entidad Federativa, edición 2005. Accesado: 10 de noviembre de 2012; Disponible en: http://www.inegi.gob.mx/prod_serv/contenidos/espanol/bvinegi/productos/integracion/pais/aepef /2005/aepef_2005_archivo1.pdf

  15. Profit J, Lee D, Zupancic JA, Papile L, Gutierrez C, Goldie SJ, Gonzalez-Pier E, Salomon JA. Clinical benefits, costs, and cost-effectiveness of neonatal intensive care in Mexico. PLoS Med. 2010 Dec 14;7(12):e1000379.

  16. Manejo de la Retinopatía del Recién Nacido Prematuro, Lineamiento Técnico, Secretaría de Salud, Centro Nacional de equidad de género y salud reproductiva, 2010. ISBN-978-970-721-441-5




2020     |     www.medigraphic.com